Hepatic profile analyses of tipranavir in Phase II and III clinical trials
-
* Corresponding author: Jaromir Mikl jmikl1@nycap.rr.com
BMC Infectious Diseases 2009, 9:203 doi:10.1186/1471-2334-9-203
Accesses
- Last 30 days: 52 accesses
- Last 365 days: 500 accesses
- All time: 1848 accesses